4.3 Article

Pain-related behavioral and electrophysiological actions of dynorphin A (1-17)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

Persistent inflammation selectively activates opioid-sensitive phasic-firing neurons within the vlPAG

Kylie B. McPherson et al.

Summary: This study classified vlPAG neurons into four distinct types based on their intrinsic firing patterns, and found that all neuron types expressed mu-opioid receptors sensitive to opioids. Persistent inflammation selectively activated a neuron type called Phasic, while acute inflammation had no effect on neuron firing patterns. This research provides new insights into understanding neuronal activation in inflammation and has implications for future pain therapies.

JOURNAL OF NEUROPHYSIOLOGY (2023)

Article Pharmacology & Pharmacy

Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain

Vadim Yakhnitsa et al.

Summary: Functional pain syndromes occur without tissue injury or noxious events. Stress is a common trigger for pain attacks in these syndromes. Recent research suggests that kappa opioid receptors in the central nucleus of amygdala contribute to functional pain syndromes, but the underlying mechanisms are still unclear. Blocking these receptors may represent a new therapeutic strategy for stress-induced functional pain syndromes.

FRONTIERS IN PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System

Claire Leconte et al.

Summary: Substance use disorders and traumatic stress-related pathologies often coexist. The KOR and DYN play a crucial role in this comorbidity, regulating the effects of stress and drug use. The DYN/KOR system is involved in anxiety, depressive symptoms, conditioned fear response, and negative reinforcement after drug use. KOR activation leads to drug-seeking behavior and cross-regulates with corticotropin-releasing factor. The sexual dimorphism of the DYN/KOR system may contribute to gender differences in patients with SUD or/and traumatic stress-related pathologies. Antagonists targeting KOR could be a promising pharmacological strategy for treating this comorbidity.

FRONTIERS IN PHARMACOLOGY (2022)

Article Neurosciences

Release of endogenous dynorphin opioids in the prefrontal cortex disrupts cognition

Antony D. Abraham et al.

Summary: Dynorphin release in the medial prefrontal cortex disrupts cognitive function via activation of kappa opioid receptors, suggesting a potential mechanism for relapse in opioid-dependent individuals. Targeting kappa opioid receptors in the prefrontal cortex may offer a potential strategy to promote abstinence from opioid dependence.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Impact of Pharmacological Manipulation of the κ-Opioid Receptor System on Self-grooming and Anhedonic-like Behaviors in Male Mice

Eduardo R. Butelman et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Article Neurosciences

Kappa Opioid Receptor Distribution and Function in Primary Afferents

Lindsey M. Snyder et al.

NEURON (2018)

Review Pharmacology & Pharmacy

The Emerging Role of Spinal Dynorphin in Chronic Pain: A Therapeutic Perspective

Sonia Podvin et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)

Article Neurosciences

A Time-Dependent History of Mood Disorders in a Murine Model of Neuropathic Pain

Ipek Yalcin et al.

BIOLOGICAL PSYCHIATRY (2011)

Review Neurosciences

Descending control of nociception: Specificity, recruitment and plasticity

M. M. Heinricher et al.

BRAIN RESEARCH REVIEWS (2009)

Article Neurosciences

Pronociceptive actions of dynorphin maintain chronic neuropathic pain

ZJ Wang et al.

JOURNAL OF NEUROSCIENCE (2001)